Pursuant to Regulation 39(3) of SEBI (Listing Obligation and Disclosure requirement), Regulation, 2015 and based on the intimation received from the Company's Registrar and Share Transfer Agent (‘RTA’) Purva Sharegistry (India) on April 22, 2024, Chemo Pharma Laboratories has informed that the Company has received a letter from the shareholder regarding loss of share certificate(s) with a request for issue of duplicate share certificate(s) in lieu thereof. The duplicate share certificate will be issued after the receipt of all necessary documents from shareholders. Details of the shareholders and share certificate are enclosed.
The above information is a part of company’s filings submitted to BSE.
